Drugs / transduced cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01279720 | Oct 2003 → Nov 2013 | severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency | Great Ormond Street Hospital for Children NHS Foundation Trust | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | transduced cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01279720 ↗ |
| Route | Intravenous | “Intravenous infusion of transduced cells” NCT01279720 ↗ |